HomeTSHA • NASDAQ
add
Taysha Gene Therapies Inc
Previous close
$1.42
Day range
$1.40 - $1.52
Year range
$1.19 - $4.32
Market cap
307.41M USD
Avg Volume
2.76M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.11M | -53.57% |
Operating expense | 22.41M | -13.06% |
Net income | -20.93M | 14.92% |
Net profit margin | -1.88K | -83.24% |
Earnings per share | -0.09 | 77.58% |
EBITDA | -20.98M | 8.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 172.74M | 283.17% |
Total assets | 200.39M | 145.75% |
Total liabilities | 91.52M | -22.87% |
Total equity | 108.87M | — |
Shares outstanding | 204.94M | — |
Price to book | 2.63 | — |
Return on assets | -30.13% | — |
Return on capital | -37.71% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -20.93M | 14.92% |
Cash from operations | -21.50M | -14.58% |
Cash from investing | -201.00K | -518.75% |
Cash from financing | 70.47M | 18,591.78% |
Net change in cash | 48.76M | 365.85% |
Free cash flow | -13.50M | 19.14% |
About
Founded
2019
Headquarters
Website
Employees
52
